Global health is a product of the Western postwar liberal international order—an order that is today besieged, says Stephen Morrison […]
Month: November 2018
Reported clinical trial of the week: Use of prednisolone in patients with rhinosinusitis (2008-000560-17)
Nick DeVito and Ben Goldacre Background The US FDA Amendments Act (FDAAA 2007) requires certain clinical trials to report their results onto ClinicalTrials.gov within one year of completion. European Union […]
Jeremy Smith: The malady of boredom
For patients experiencing long hospital stays, the hardest part to endure may not be the pain or inconvenience of treatment but boredom, says Jeremy Smith […]
Gaining patients’ perspectives on respiratory diseases
Two researchers describe how including patient input in their study provided valuable insights […]
Global health disruptors: SARS and Ebola
SARS and Ebola redefined the World Health Organization, but didn’t resolve its funding problems, says Suerie Moon […]
Global health disruptors: The Bill and Melinda Gates Foundation
The Gates Foundation has expanded the power of private philanthropic organisations, say Marlee Tichenor and Devi Sridhar […]
“Researchers don’t know what they’re missing”—the impact of patient involvement in research
Through their experience of living with a health condition, patients gain experiential knowledge that no one else has. Researchers working in health research typically lack this knowledge, but often don’t […]
Global health disruptors: The rise of civil society
Civil society organisations have had profound influence on global governance, say Nanoot Mathurapote and Weerasak Putthasri […]
Joanna Crocker: Time to embrace patient involvement in clinical trials?
This review paper is a significant step in a long and bumpy journey. The idea started four years ago, when I began a new post as research fellow in patient […]
Global health disruptors: Doha declaration
Power imbalances threaten access to medicines for all countries, says Sharon Friel […]